Home › Bronchiolitis Obliterans Syndrome › Virginia
Bronchiolitis Obliterans Syndrome clinical trials in Virginia
4 studies for Bronchiolitis Obliterans Syndrome are looking for participants at sites in Virginia.
Cities in Virginia
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
- Virginia Commonwealth University Massey Cancer Center, Richmond
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 15, 2026 · NCT06585774Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy
- University of Virginia Comprehensive Cancer Center, Charlottesville
- Virginia Commonwealth University, Richmond
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 5, 2026 · NCT06660355A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- Virginia Commonwealth University, North Hospital, Richmond
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 20, 2026 · NCT06615050A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Virginia Commonwealth University, Richmond
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 15, 2025 · NCT06619561From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.